Please refer the enclosed intimation letter
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare Technologies' Board approved several key decisions including recommending a final dividend of Rs. 7 per share for FY 2025-26 (total dividend Rs. 9.33 per share post-bonus adjustment). The company appointed Price Waterhouse Chartered Accountants LLP as new statutory auditors for a 5-year term, replacing M S K A & Associates who completed their tenure. CEO Mr. Rahul Franklin Guha was re-appointed for 5 years. Two non-independent directors—Mr. Dharmil Nirupam Sheth and Dr. Dhaval Rajesh Shah—resigned on the same day citing personal commitments. Two new directors from API Holdings (Uday Patel Kadam and Gaurav Verma) were appointed. The board also approved investing up to Rs. 5.5 crore in subsidiary Think Health Diagnostics and proposed amendments to the Memorandum of Association to expand business scope.
The coordinated resignation of two directors on the same day may raise minor governance concerns, though the board appears stable with new appointments. The re-appointment of the CEO, new auditor appointment, and continued dividend policy are positive signals for shareholders.